Research output per year
Research output per year
Personal profile
Fields of Science
- 3122 Cancers
- 1182 Biochemistry, cell and molecular biology
International and National Collaboration
Publications and projects within past five years.
-
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts
Olesinski, E. A., Bhatia, K. S., Wang, C., Pioso, M. S., Lin, X. X., Mamdouh, A. M., Ng, S. X., Sandhu, V., Jasdanwala, S. S., Yilma, B., Bohl, S., Ryan, J. A., Malani, D., Luskin, M. R., Kallioniemi, O., Porkka, K., Adamia, S., Chng, W. J., Osato, M., Weinstock, D. M., & 3 others, 1 May 2024, In: Blood cancer discovery. 5, 3, p. 180-201 22 p.Research output: Contribution to journal › Article › Scientific › peer-review
-
Datamassojen hallinta syöpäpotilaiden hoidossa
Brück, O. & Porkka, K., 2024, In: Duodecim. 140, 2, p. 158-164 7 p.Research output: Contribution to journal › Review Article › peer-review
-
Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia
Adnan Awad, S., Dufva, O., Klievink, J., Karjalainen, E., Ianevski, A., Pietarinen, P., Kim, D., Potdar, S., Wolf, M., Lotfi, K., Aittokallio, T., Wennerberg, K., Porkka, K. & Mustjoki, S., 21 May 2024, In: Cell Reports Medicine. 5, 5, 23 p., 101521.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
Pratz, K. W., Jonas, B. A., Pullarkat, V., Thirman, M. J., Garcia, J. S., Döhner, H., Récher, C., Fiedler, W., Yamamoto, K., Wang, J., Yoon, S. S., Wolach, O., Yeh, S. P., Leber, B., Esteve, J., Mayer, J., Porkka, K., Illés, Á., Lemoli, R. M., Turgut, M., & 7 others, Apr 2024, In: American Journal of Hematology. 99, 4, p. 615-624 10 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia
Eldfors, S., Saad, J., Ikonen, N., Malani, D., Vähä-Koskela, M., Gjertsen, B. T., Kontro, M., Porkka, K. & Heckman, C. A., 9 Apr 2024, In: Blood advances. 8, 7, p. 1621-1633 13 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile
-
Syöpäsäätiö 2024-2026 / Porkka
Porkka, K. & Ryzhenkov, A.
Syöpäsäätiö sr Cancerstiftelsen sr
01/01/2024 → 31/12/2026
Project: Foundations (Private Foundations, Non-Profit Foundations, Charitable Trusts)
-
Yksilöllisen syöpähoidon professuuri
Roche Oy, Bayer Oy, Novartis Finland Oy
01/12/2021 → 31/12/2029
Project: Corporate funding
-
Studies of axitinib and axitinib drug combinations as BCR-ABL1 T315I -selective therapies for use in drug-resistant CML and Ph+ ALL
Wennerberg, K., Repasky, G., Pemovska, T. & Porkka, K.
01/11/2013 → …
Project: Research project
-
Role of polysialic acid in human neuroblastoma
Finne, J., Vettenranta, K., Sariola, H., Porkka, K. & Lehti, T.
Project: Research project